Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ludwig Oxford's Yang Shi has been announced as a Fellow of the Academy of Medical Sciences

Yang Shi, member of the Oxford Branch of Ludwig Institute for Cancer Research and Professor of Epigenetics at the University of Oxford has been elected as a Fellow to the Academy of Medical Sciences. Election as a Fellow is typically reserved for scientists who have made “exceptional contributions to the medical sciences, either in the form of original discovery or of sustained contributions to scholarship” as stated by the Academy.

Professor Shi has made significant contributions to epigenetics, studying the chemical modifications made to DNA and its histone protein packaging in the cell’s nucleus. Of particular note, Yang’s 2004 discovery of the enzyme LSD1, which erases methyl marks from histones, changed the 40-year-old assumption that considered histone methylation irreversible. We are delighted that his achievements have been recognised in this announcement.

The full article detailing Yang’s achievement can be found at the Ludwig Cancer Research website.

Similar stories

Professor Yang Shi honoured by the Royal Society

Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research